Petrolatum

Petrolatum (petroleum jelly, white soft paraffin) is a purified hydrocarbon ointment. It is one of the most occlusive emollient bases: it reduces Transepidermal Water Loss by more than 98%, compared with 20–30% for Lanolin, and carries “essentially no risk” of Allergic Contact Dermatitis (Cutis 2023). That makes it the standard substitute for children with suspected lanolin allergy, and a common chin barrier in Drool Dermatitis. In a Cape Town RCT, petroleum jelly (or glycerine:petroleum jelly 1:2) worked as well as emulsifying ointment, which is why it anchors cheap regimens in South African Eczema Guidance. For a toddler with dry, itchy skin, the AAD-style “soak and smear” advice is to bathe, then cover the skin with a thick ointment such as petroleum jelly, which relieves itch better than a cream or lotion (see Soak and Seal).

Petrolatum [part-of] Emollient Therapy Petrolatum [prevents] Transepidermal Water Loss Petrolatum [relates] Lanolin Petrolatum [relates] Soak and Seal

Mechanism: more than a surface film. Ghadially, Halkier-Sorensen and Elias (JAAD 1992) tested the assumption that petrolatum simply seals the skin. If that were true, it should slow barrier repair, as plastic occlusion does. In human volunteers whose barrier was stripped with acetone, Vaseline instead accelerated barrier recovery. Tracer and ruthenium-tetroxide staining showed it had moved into the gaps between corneocytes at every level of the stratum corneum, replacing intercellular lipid bilayers. The authors concluded it “neither forms nor acts like an epicutaneous impermeable membrane”, so normal repair continues under it. Later work by Czarnowicki (summarised in Divya et al. 2024) found petrolatum also raised antimicrobial-peptide gene expression and epidermal differentiation markers in atopic skin, and lowered T-cell and dendritic-cell counts. That may matter for toddlers prone to Staphylococcus aureus colonisation, though it is mechanistic, not a clinical trial outcome.

Petrolatum [supports] Skin Barrier Dysfunction Petrolatum [relates] Staphylococcus aureus

Conflict: [Ghadially et al., JAAD, 1992] says petrolatum permeates the stratum corneum and accelerates barrier recovery. [Elias & Wakefield, Clin Rev Allergy Immunol, 2011] says non-physiologic lipids “such as petrolatum and lanolin” impede rather than correct the underlying barrier defect, favouring physiological-lipid (Ceramides) formulas. Unresolved — add to open_questions.

Infant prevention trials. Pilot studies suggested daily paraffin-based emollient from birth could cut eczema risk by up to 50% (J Clin Med 2022 review). The large trials did not confirm it. BEEP Trial (1,394 high-risk UK newborns, Diprobase cream or Doublebase gel daily for a year) and PreventADALL Trial (bath oil and facial cream from the first weeks) did not reduce eczema, and BEEP found more skin infections. The Cochrane review (Kelleher 2022; 33 RCTs, 25,827 infants) concluded that skin care in the first year probably does not prevent eczema (RR 1.03), may increase IgE food allergy (RR 2.53, low certainty) and probably increases skin infection (RR 1.33). These trials are about prevention in babies; for a toddler who already has Atopic Dermatitis, regular emollient remains first-line treatment.

BEEP Trial [contradicts] Petrolatum PreventADALL Trial [contradicts] Petrolatum Petrolatum [treats] Atopic Dermatitis

Safety myths. The main online worry is contamination with polycyclic aromatic hydrocarbons (PAHs), carcinogens present in crude petroleum. Divya et al. (2024) report that PAH concentrations in refined petrolatum are negligible, with no evidence of systemic exposure, toxicity or carcinogenicity from topical use. When refined to FDA and European Pharmacopoeia standards it is even permitted in food, and the FDA lists it as an active ingredient in over-the-counter skin protectants. True allergy is rare: about 0.03% of patients patch-tested for suspected contact dermatitis, and 0% of 440 post-surgical wound patients (vs 0.9% with bacitracin). Petrolatum itself has an NFPA flammability score of 0. The real fire hazard is different: clothing and bedding soaked in any paraffin-containing emollient burn faster, and the MHRA says the risk cannot be excluded for paraffin-free ones (see Emollient Fire Risk). The only population with an infection signal is extremely-low-birth-weight preterm neonates, where trials found more systemic candidiasis and bacterial sepsis; this does not apply to toddlers. What parents report (evidence: anecdotal): in an r/eczema thread about a 5-month-old, a parent listed “aquaphor, Vaseline, olive oil” among the first things tried before moving on to coconut oil. Clinicians note that some parents find petrolatum too greasy for everyday use, so a cream may be offered instead (Medscape).

Petrolatum [relates] Emollient Fire Risk FDA [regulates] Petrolatum Petrolatum [relates] Mineral Oil

Connections

• Lanolin — recommended lanolin-free substitute, source: Cutis 2023
• Emollient Therapy — common ointment base, source: Cutis 2023
• Emollient Fire Risk — paraffin-based emollients flammable on fabric, source: MHRA (see note)
• South African Eczema Guidance — petroleum jelly / glycerine:petroleum 1:2 equivalent to emulsifying ointment in Cape Town RCT, source: Hlela 2015 SAMJ
• Skin Barrier Dysfunction — permeates stratum corneum and accelerates barrier recovery, source: Ghadially 1992
• BEEP Trial — daily paraffin emollient from birth did not prevent eczema, source: Chalmers 2020 Lancet
• PreventADALL Trial — early emollient/bath oil did not prevent AD, source: J Clin Med 2022 review
• Cochrane — infant skin care probably does not prevent eczema, source: Kelleher 2022
• Ceramides — physiological-lipid alternative; Elias argues petrolatum does not correct lipid defect, source: Elias & Wakefield 2011
• Mineral Oil — liquid fraction of the same refined hydrocarbons, source: Divya 2024
• FDA — OTC skin-protectant active ingredient; refined grade, source: Divya 2024